ArticleJournal of molecular modeling2022
Utilization of boron carbide nanosheet in the recognition cathinone drug concentration in the human body.
Article in Journal of molecular modeling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study adopted density functional theory (DFT) and analyzed the interaction of the conventional cathinone (CA) drug with perfect and defected monolayer nanosheets of boron carbide (BC3). BC3 was found to have poor interactions with CA. Hence, the perfect nanosheets had poor CA sensitivity. The potential of single and double vacancy (SV and DV) defects in the nanosheet to strengthen the nanosheet-drug interaction were assessed. The energy of adsorption of CA adsorption onto SV-BC3 and DV-BC3 was nearly - 23.78 and - 15.32 kcal/mol, respectively. The adsorption substantially altered the work function and bandgap of the defected nanosheets. However, the perfect BC3 experienced a change merely in bandgap during the drug adsorption-the work function change was slight. Thus, the defected nanosheets could be Φ-type and electronic sensors of CA, whereas the perfect nanosheet has the potential to be solely an electronic detector of CA. A larger dielectric constant led to a significant change in the adsorption energy. Furthermore, DV-BC3 considerably changed in magnetic characteristics due to the drug adsorption.
Indexed as
Identifiers
35986172What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.